FOM Industries
MEDRiGHT Dispenser Cap,
The newest innovation in prescription delivery systems.
FDA Registered Class 1 Medical Device
Signed in as:
filler@godaddy.com
MEDRiGHT Dispenser Cap,
The newest innovation in prescription delivery systems.
FDA Registered Class 1 Medical Device
The newest prescription management system for retail pharmacy vials.
The MEDRiGHT cap features fluorescent icons SUN/Moon or AM/PM as a secondary visual aid while in use. The dispenser is Rheumatoid Arthritis friendly for secure handling and features a built-in safety tab to reduce prescription errors.
The MEDRiGHT designed to adhere to Tab-lock and Twist-lock medication vials.
FOM Industries is pioneering advancements in product design, user interface improvements, and production methods utilized in their cutting-edge MedRight dispenser system, solidifying the company's commitment to delivering high-quality solutions that prioritize patient safety and wellbeing.
FDA Consumer Updates- 4 Medication Safety Tips for Older Adults
CDC, Bringing Awareness To Help Prescription Overdose
Overdosing Non-fatal Data by the CDC
FDA's Framework Aims to Prevent Drug Overdose and Reduce Death
Inappropriate Use of Medication
Medication Without Harm
Arthritis is Osteoarthritis & Rheumatoid arthritis.
• 1-5 Adults (21.2%) or about 53.2 million people have been clinically diagnosed with Arthritis and more common w/ Woman @ 20.9% vs Men @ 16.3% in the U.S.
• U.S. Veterans have an alarming rate of 24.2% then non-Veterans at 18.5% and more than half of the U.S. adults (51.7%) with Arthritis are of working age (18 to 64 years) and creates limits to their everyday.
In the United States will see the largest increases in Alzheimer’s disease and related dementias between 2015 and 2060.
Dementia is not a specific disease but rather a general term for the impaired ability to remember, think, or make decisions that interferes with doing everyday activities.
Alzheimer’s disease is the most common type of dementia. Current estimates are that about 5.8 million people in the United States have Alzheimer’s disease and related dementias, including 5.6 million aged 65 and older and about 200,000 under age 65 with younger-onset Alzheimer’s. By 2060, the number of Alzheimer’s disease cases is predicted to rise to an estimated 14 million people, with minority populations being affected the most.